B-intervention	0	8	Physical
I-intervention	9	17	Activity
I-intervention	18	22	With
I-intervention	23	26	and
I-intervention	27	34	Without
I-intervention	35	38	Arm
I-intervention	39	46	Sleeves
O	46	47	:
O	48	58	Compliance
O	59	62	and
O	63	70	Quality
O	71	73	of
O	74	78	Life
O	79	84	After
O	85	91	Breast
O	92	98	Cancer
O	99	106	Surgery
O	106	107	-
O	107	108	A
O	109	119	Randomized
O	120	130	Controlled
O	131	136	Trial
O	136	137	.

O	138	143	After
O	144	150	breast
O	151	157	cancer
O	158	165	surgery
O	166	174	patients
O	175	178	are
O	179	181	at
O	182	188	higher
O	189	193	risk
O	194	196	of
O	197	207	lymphedema
O	208	219	development
O	220	223	and
O	224	234	decreasing
O	235	243	physical
O	244	252	activity
O	253	254	(
O	254	256	PA
O	256	257	)
O	257	258	,
O	259	261	as
O	262	266	well
O	267	269	as
O	270	280	decreasing
O	281	287	health
O	287	288	-
O	288	295	related
O	296	303	quality
O	304	306	of
O	307	311	life
O	312	313	(
O	313	318	HRQOL
O	318	319	)
O	319	320	.

O	321	324	The
O	325	328	aim
O	329	331	of
O	332	335	the
O	336	341	study
O	342	345	was
O	346	348	to
O	349	356	compare
O	357	360	the
O	361	366	level
O	367	369	of
O	370	372	PA
O	373	376	and
O	377	382	HRQOL
O	383	385	in
O	386	391	women
O	392	397	after
O	398	404	breast
O	405	411	cancer
O	412	419	surgery
O	420	425	using
O	426	431	light
O	432	435	arm
O	436	447	compression
O	448	452	with
O	453	458	women
O	459	462	not
O	463	468	using
O	469	480	compression
O	481	482	1
O	483	487	year
O	488	493	after
O	494	505	oncological
O	506	515	treatment
O	515	516	.

B-total-participants	517	522	Forty
I-total-participants	522	523	-
I-total-participants	523	527	five
O	528	533	women
O	534	538	were
O	539	553	preoperatively
O	554	562	randomly
O	563	571	assigned
O	572	574	to
O	575	576	a
O	577	588	compression
O	589	594	group
O	595	596	(
O	596	598	CG
O	598	599	,
O	600	601	n
O	602	603	=
B-intervention-participants	604	606	23
O	606	607	)
O	608	610	or
O	611	613	to
B-control	614	616	no
I-control	617	628	compression
I-control	629	634	group
O	635	636	(
O	636	639	NCG
O	639	640	,
O	641	642	n
O	643	644	=
B-control-participants	645	647	22
O	647	648	)
O	648	649	.

O	650	653	Arm
O	654	661	volumes
O	662	666	were
O	667	675	measured
O	676	682	before
O	683	690	surgery
O	691	694	and
O	695	697	12
O	698	704	months
O	705	715	thereafter
O	715	716	.

O	717	720	The
O	721	723	CG
O	724	732	received
O	733	741	circular
O	741	742	-
O	742	746	knit
O	747	754	sleeves
O	755	757	in
O	758	769	compression
O	770	775	class
O	776	777	1
O	778	781	for
O	782	787	daily
O	788	795	wearing
O	796	798	in
O	799	802	the
O	803	816	postoperative
O	817	823	period
O	824	826	up
O	827	829	to
O	830	831	1
O	832	836	year
O	836	837	.

O	838	842	Both
O	843	849	groups
O	850	859	underwent
O	860	861	a
O	862	874	standardized
O	875	883	physical
O	884	892	exercise
O	893	900	program
O	900	901	.

O	902	904	PA
O	905	909	with
O	910	913	the
O	914	919	short
O	920	927	version
O	928	930	of
O	931	944	International
O	945	953	Physical
O	954	962	Activity
O	963	976	Questionnaire
O	977	978	(
O	978	982	IPAQ
O	982	983	)
O	983	984	,
O	985	995	compliance
O	995	996	,
O	997	1000	and
O	1001	1006	HRQOL
O	1007	1009	by
O	1010	1015	EORTC
O	1016	1019	QLQ
O	1019	1020	-
O	1020	1023	C30
O	1024	1027	and
O	1028	1031	QLQ
O	1031	1032	-
O	1032	1036	BR23
O	1037	1051	questionnaires
O	1052	1055	was
O	1056	1064	assessed
O	1065	1067	in
O	1068	1072	both
O	1073	1079	groups
O	1080	1081	1
O	1082	1086	year
O	1087	1092	after
O	1093	1100	surgery
O	1100	1101	.

O	1102	1107	After
O	1108	1109	1
O	1110	1114	year
O	1115	1126	observation
O	1127	1130	the
O	1131	1133	CG
O	1134	1140	showed
O	1141	1154	significantly
O	1155	1160	lower
O	1161	1165	mean
O	1166	1174	affected
B-outcome	1175	1178	arm
I-outcome	1179	1185	volume
O	1186	1194	compared
O	1195	1197	to
O	1198	1201	NCG
O	1201	1202	.

O	1203	1206	The
B-outcome	1207	1212	total
I-outcome	1213	1215	PA
O	1216	1217	(
O	1217	1227	calculated
O	1228	1230	as
O	1231	1234	the
O	1235	1238	sum
O	1239	1241	of
O	1242	1250	vigorous
O	1251	1259	moderate
O	1260	1269	exercises
O	1270	1273	and
O	1274	1281	walking
O	1281	1282	)
O	1283	1286	was
O	1287	1295	markedly
O	1296	1302	higher
O	1303	1309	within
O	1310	1313	the
O	1314	1316	CG
O	1316	1317	,
O	1318	1322	with
O	1323	1325	no
O	1326	1336	difference
O	1337	1339	in
O	1340	1350	particular
O	1351	1355	IPAQ
O	1356	1361	items
O	1361	1362	.

O	1363	1368	There
O	1369	1373	were
O	1374	1376	no
O	1377	1389	correlations
O	1390	1397	between
O	1398	1406	reported
O	1407	1409	PA
O	1410	1415	items
O	1416	1419	and
O	1420	1428	observed
B-outcome	1429	1432	arm
I-outcome	1432	1433	/
I-outcome	1433	1438	edema
I-outcome	1439	1445	volume
O	1446	1448	or
B-outcome	1449	1453	body
I-outcome	1454	1458	mass
I-outcome	1459	1464	index
I-outcome	1465	1472	changes
O	1472	1473	.

O	1474	1477	The
O	1478	1481	QLQ
O	1481	1482	-
O	1482	1486	BR23
O	1487	1495	revealed
O	1496	1500	only
O	1501	1507	better
B-outcome	1508	1514	sexual
I-outcome	1515	1526	functioning
O	1527	1528	(
O	1528	1529	p
O	1530	1531	=
O	1532	1533	0
O	1533	1534	.
O	1534	1537	014
O	1537	1538	)
O	1539	1542	and
O	1543	1550	greater
B-outcome	1551	1556	upset
I-outcome	1557	1559	by
I-outcome	1560	1564	hair
I-outcome	1565	1569	loss
O	1570	1572	in
O	1573	1576	NCG
O	1577	1578	(
O	1578	1579	p
O	1580	1581	=
O	1582	1583	0
O	1583	1584	.
O	1584	1586	01
O	1586	1587	)
O	1587	1588	.

O	1589	1592	The
O	1593	1602	available
O	1603	1607	data
O	1608	1616	indicate
O	1617	1621	that
O	1622	1629	wearing
O	1630	1641	compression
O	1642	1649	sleeves
O	1650	1657	neither
O	1658	1667	interfere
O	1668	1672	with
O	1673	1676	the
O	1677	1682	level
O	1683	1685	of
O	1686	1688	PA
O	1689	1692	nor
O	1693	1701	decrease
O	1702	1709	quality
O	1710	1712	of
O	1713	1717	life
O	1718	1719	1
O	1720	1724	year
O	1725	1730	after
O	1731	1737	breast
O	1738	1744	cancer
O	1745	1752	surgery
O	1752	1753	.
